Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0256 | 0.3887 | 1 | |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0307 | 0.4823 | 1 |
Brugia malayi | hypothetical protein | 0.0146 | 0.1847 | 0.3829 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0227 | 0.3354 | 0.6953 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0307 | 0.4823 | 1 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0226 | 0.332 | 0.6882 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0307 | 0.4823 | 1 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0307 | 0.4823 | 1 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0307 | 0.4823 | 1 |
Mycobacterium tuberculosis | Probable enoyl-CoA hydratase EchA14 (enoyl hydrase) (unsaturated acyl-CoA hydratase) (crotonase) | 0.029 | 0.4521 | 1 |
Brugia malayi | TAR-binding protein | 0.0121 | 0.1373 | 0.2845 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.0256 | 0.3887 | 0.5 |
Brugia malayi | Pax transcription factor protein 2 | 0.0226 | 0.332 | 0.6882 |
Onchocerca volvulus | 0.0226 | 0.332 | 0.7219 | |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0307 | 0.4823 | 0.1532 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.0256 | 0.3887 | 0.8059 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0307 | 0.4823 | 0.5 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0307 | 0.4823 | 1 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0307 | 0.4823 | 1 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0307 | 0.4823 | 1 |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0307 | 0.4823 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0121 | 0.1373 | 0.2845 |
Trichomonas vaginalis | Sialidase-1 precursor, putative | 0.0585 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.1847 | 0.3829 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0121 | 0.1373 | 0.2845 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0307 | 0.4823 | 1 |
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0307 | 0.4823 | 0.5 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0307 | 0.4823 | 0.5 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0307 | 0.4823 | 1 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0307 | 0.4823 | 0.5 |
Brugia malayi | RNA binding protein | 0.0121 | 0.1373 | 0.2845 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.0256 | 0.3887 | 0.8059 |
Brugia malayi | MH2 domain containing protein | 0.0227 | 0.3354 | 0.6953 |
Loa Loa (eye worm) | RNA binding protein | 0.0121 | 0.1373 | 0.2845 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.0256 | 0.3887 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0121 | 0.1373 | 0.2845 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0227 | 0.3354 | 0.6953 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0307 | 0.4823 | 0.1532 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 32.21 % | Inhibition of T type calcium channel subunit alpha1G expressed in HEK293 cells assessed as effect on KCl-induced increase in intracellular calcium level at 10 uM by FDSS assay | ChEMBL. | 17150365 |
Inhibition (binding) | = 32.21 % | Inhibition of T type calcium channel subunit alpha1G expressed in HEK293 cells assessed as effect on KCl-induced increase in intracellular calcium level at 10 uM by FDSS assay | ChEMBL. | 17150365 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.